HeiLongJiang ZBD Pharmaceutical News

Jumbo Island (603567): Significant increase in third quarter results

Nov 6, 2023 17:02

Jumbo Island (603567): 2023Q3 profit growth exceeds expectations, and the advantages of Chinese herbal medicine trade are further highlighted

Nov 2, 2023 16:27

Treasure Island (603567): Product line continues to be optimized, innovation and research and development are progressing in an orderly manner

上海證券Aug 24, 2023 18:52

Treasure Island (603567): A scarce standard for the vertical integration of traditional Chinese medicine

國聯證券Aug 3, 2023 00:00

Treasure Island (603567): Performance Resumes High Growth, Equity Incentives Increase Motivation, Treasure Island

華金證券Jun 7, 2023 00:00

Treasure Island (603567): Open up the entire Chinese medicine industry chain, innovate R&D and open up a new blue ocean of business

長城證券Mar 8, 2023 00:00

Treasure Island (603567): A sharp increase in commercial revenue is steadily advancing the research pipeline

西南證券Aug 30, 2022 00:00

Treasure Island (603567): Upgrading and building a platform for the entire Chinese medicine industry chain, innovative medicines have been very effective

信達證券Aug 4, 2022 18:41

Zhenbao Island (603567): the performance is affected by the epidemic and the policy is good for the sales of traditional Chinese medicine products.

西南證券May 6, 2022 00:00

[Shanghai Securities] Zhenbao Island: a traditional Chinese medicine preparation enterprise with cardiovascular traditional Chinese medicine injection as the core

上海證券Apr 20, 2015 00:00

[CITIC Construction Investment Securities] Jumbo Island: A well-known brand enterprise of proprietary Chinese medicines

中信建投證券Apr 15, 2015 00:00

[Shen Wan Hongyuan] Zhenbao Island: with traditional Chinese medicine injection as the core variety, the cardio-cerebrovascular brand has obvious advantages.

申萬宏源Apr 14, 2015 00:00

[Hengtai Securities] Zhenbaodao: the initial stock price pressure of the company is expected to be 53-58 yuan.

恆泰證券Apr 14, 2015 00:00

Analysis of new shares of Zhenbao Island (603567): with traditional Chinese medicine injection as the core variety, the cardio-cerebrovascular brand has obvious advantages.

申銀萬國Apr 14, 2015 00:00

Zhenbao Island (603567): with traditional Chinese medicine injection as the core variety, cardio-cerebrovascular brand has obvious advantages.

申萬宏源研究Apr 14, 2015 00:00

[Huatai] Zhenbao Island: recommended purchase on April 14th

華泰證券Apr 13, 2015 00:00

Zhenbao Island (603567): recommended purchase on April 14

華泰證券Apr 13, 2015 00:00

[Societe Generale Securities] Zhenbao Island: traditional Chinese medicine injection as the core, steady performance growth

興業證券Apr 8, 2015 00:00